Bayesian inference of the sites of perturbations in metabolic pathways via Markov chain Monte Carlo
Open accessThe DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Abstract
Motivation: Genetic modifications or pharmaceutical interventions can influence multiple sites in metabolic pathways, and often these are ‘distant’ from the primary effect. In this regard, the ability to identify target and off-target effects of a specific compound or gene therapy is both a major challenge and critical in drug discovery. Results: We applied Markov Chain Monte Carlo (MCMC) for parameter estimation and perturbation identification in the kinetic modeling of metabolic pathways. Variability in the steady-state measurements in cells taken from a population can be caused by differences in initial conditions within the population, by variation of parameters among individuals and by possible measurement noise. MCMC-based parameter estimation is proposed as a method to help in inferring parameter distributions, taking into account uncertainties in the initial conditions and in the measurement data. The inferred parameter distributions are then used to predict changes in the network via a simple classification method. The proposed technique is applied to analyze changes in the pathways of pyruvate metabolism of mutants of Lactococcus lactis, based on previously published experimental data. Availability: MATLAB code used in the simulations is available from ftp://anonymous@dbkweb.mib.man.ac.uk/pub/Bioinformatics_BJ.zip Contact: bayujw@ieee.org Supplementary information: Supplementary data are available at Bioinformatics online.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Equation of State Calculations by Fast Computing Machines
Metropolis, N., Rosenbluth, A. W., Rosenbluth, M. N., Teller, A. H., & Teller, E. (1953) · The Journal of Chemical Physics · doi:10.1063/1.1699114 · Cited by 37,192
Gelman, A., Carlin, J. B., Stern, H. S., & Rubin, D. B. (2003) · doi:10.1201/9780429258480 · Cited by 27,276
Markov Chain Monte Carlo in Practice
(1995) · Chapman & Hall/CRC eBooks · doi:10.1201/b14835 · Cited by 7,757
Markov Chain Monte Carlo in Practice
Gasparini, M. (1997) · Technometrics · doi:10.1080/00401706.1997.10485132 · Cited by 1,879
Betts, J. C., Lukey, P. T., Robb, L. C., McAdam, R. A., & Duncan, K. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02779.x · Cited by 1,395 · cited 1×
“A related approach is to use DNA microarray analysis for validating drug targets and off-targets as pursued by Betts et al .”
MethodShapiro, A. (2003) · Handbooks in Operations Research and Management Science · doi:10.1016/s0927-0507(03)10006-0 · Cited by 916
Davey, H. M., & Kell, D. B. (1996) · Microbiological Reviews · doi:10.1128/mr.60.4.641-696.1996 · Cited by 879
Self-citationStatistical strategies for avoiding false discoveries in metabolomics and related experiments
Broadhurst, D. I., & Kell, D. B. (2007) · Metabolomics · doi:10.1007/s11306-006-0037-z · Cited by 817
Self-citationTeusink, B., Passarge, J., Reijenga, C. A., Esgalhado, E., van der Weijden, C. C., Schepper, M., Walsh, M. C., Bakker, B. M., van Dam, K., Westerhoff, H. V., et al. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01527.x · Cited by 694
Parsons, A. B., Brost, R. L., Ding, H., Li, Z., Zhang, C., Sheikh, B., Brown, G. W., Kane, P. M., Hughes, T. R., & Boone, C. (2004) · Nature Biotechnology · doi:10.1038/nbt919 · Cited by 675
Drug target validation and identification of secondary drug target effects using DNA microarrays
Marton, M. J., DeRisi, J. L., Bennett, H. A., Iyer, V. R., Meyer, M. R., Roberts, C. J., Stoughton, R., Burchard, J., Slade, D., Dai, H., et al. (1998) · Nature Medicine · doi:10.1038/3282 · Cited by 643
Genomic profiling of drug sensitivities via induced haploinsufficiency
Giaever, G., Shoemaker, D. D., Jones, T. W., Liang, H., Winzeler, E. A., Astromoff, A., & Davis, R. W. (1999) · Nature Genetics · doi:10.1038/6791 · Cited by 570
Exploring the Mode-of-Action of Bioactive Compounds by Chemical-Genetic Profiling in Yeast
Parsons, A. B., Lopez, A., Givoni, I. E., Williams, D. E., Gray, C. A., Porter, J., Chua, G., Sopko, R., Brost, R. L., Ho, C.-H., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.040 · Cited by 515
Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?
Dobson, P. D., & Kell, D. B. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2438 · Cited by 475 · cited 1×
“Drug discovery is now recognized as a problem of integrative systems biology requiring genome-wide analyses (see, e.g. Butcher, 2005; Dobson and Kell, 2008; Williams, 2005).”
BackgroundSelf-citationKoning, W. D., & Dam, K. V. (1992) · Analytical Biochemistry · doi:10.1016/0003-2697(92)90149-2 · Cited by 455
Systems biology, metabolic modelling and metabolomics in drug discovery and development
Kell, D. B. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.10.004 · Cited by 297
Self-citationCan cell systems biology rescue drug discovery?
Butcher, E. C. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1754 · Cited by 276
Hoefnagel, M. H. N., Starrenburg, M. J. C., Martens, D. E., Hugenholtz, J., Kleerebezem, M., Van Swam, I. I., Bongers, R., Westerhoff, H. V., & Snoep, J. L. (2002) · Microbiology · doi:10.1099/00221287-148-4-1003 · Cited by 214
Clarke, P. A., te Poele, R., Wooster, R., & Workman, P. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00785-7 · Cited by 184
Bayesian ranking of biochemical system models
Vyshemirsky, V., & Girolami, M. A. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btm607 · Cited by 181
Yeast genome-wide drug-induced haploinsufficiency screen to determine drug mode of action
Baetz, K., McHardy, L., Gable, K., Tarling, T., Rebérioux, D., Bryan, J., Andersen, R. J., Dunn, T., Hieter, P., & Roberge, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307122101 · Cited by 177
Ott, K.-H., Aranı́bar, N., Singh, B., & Stockton, G. W. (2003) · Phytochemistry · doi:10.1016/s0031-9422(02)00717-3 · Cited by 164
Metabolic control analysis of moiety‐conserved cycles
HOFMEYR, J. S., KACSER, H., & van der MERWE, K. J. (1986) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1986.tb09534.x · Cited by 159
Battogtokh, D., Asch, D. A., Case, M. E., Arnold, J., & Schüttler, H.-B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262658899 · Cited by 124
Lüdtke, N., Panzeri, S., Brown, M., Broomhead, D. S., Knowles, J. D., Montemurro, M. A., & Kell, D. B. (2007) · Journal of The Royal Society Interface · doi:10.1098/rsif.2007.1079 · Cited by 119
Self-citationSchemes of flux control in a model of Saccharomyces cerevisiae glycolysis
Pritchard, L., & Kell, D. B. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03055.x · Cited by 102
Self-citationApplication of abductive ILP to learning metabolic network inhibition from temporal data
Tamaddoni-Nezhad, A., Chaleil, R., Kakas, A., & Muggleton, S. (2006) · Machine Learning · doi:10.1007/s10994-006-8988-x · Cited by 92
Bringing metabolic networks to life: integration of kinetic, metabolic, and proteomic data
Liebermeister, W., & Klipp, E. (2006) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-3-42 · Cited by 82
Probe-level measurement error improves accuracy in detecting differential gene expression
Liu, X., Milo, M., Lawrence, N. D., & Rattray, M. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl361 · Cited by 75
Self-citationAutomated Mode-of-Action Detection by Metabolic Profiling
Aranı́bar, N., Singh, B., Stockton, G. W., & Ott, K. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5350 · Cited by 60
Bayesian parameter estimation with informative priors for nonlinear systems
Coleman, M. C., & Block, D. E. (2005) · AIChE Journal · doi:10.1002/aic.10667 · Cited by 52
SABIO-RK: a database for biochemical reactions and their kinetics
Rojas, I., Golebiewski, M., Kania, R., Krebs, O., Mir, S., Weidemann, A., & Wittig, U. (2007) · BMC Systems Biology · doi:10.1186/1752-0509-1-s1-s6 · Cited by 36
Williams, M. J. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.08.019 · Cited by 34
Chapal, N., Molina, L., Molina, F., Laplanche, M., Pau, B., & Petit, P. (2004) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2004.00258.x · Cited by 33
Protein engineering of pyruvate carboxylase
Sueda, S., Islam, M. N., & Kondo, H. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04051.x · Cited by 24
Cited by
Structure and dynamics of molecular networks: A novel paradigm of drug discovery
Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G., & Nussinov, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.016 · Cited by 892
“Name Content Website References KEGG Metabolic pathway resource http://kegg.jp Kanehisa et al., 2012 MetaCyc http://metacyc.org Caspi et al., 2012 HumanCyc http://humancyc.org Romero et al., 2005 SMPDB Small Molecule (e.g., drug) Pathway Database http://smpdb.ca Frolkis et al., 2010 HMDB Human Metabolome Database http…”
MethodKell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
“[2314-2320]) – for a recent example see [2321].”
BackgroundSelf-citationKell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
Self-citationKell, D. B., & Goodacre, R. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2013.07.014 · Cited by 169
Self-citationKell, D. B., Dobson, P. D., Bilsland, E., & Oliver, S. G. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.11.008 · Cited by 154
Self-citation
Metadata
- Authors
- Jayawardhana, B., Kell, D. B., & Rattray, M.
- Affiliations
- University of Manchester (GB)
- Corresponding author
- Jayawardhana, Bayu
- Venue
- Bioinformatics
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-03-20
- Volume
- 24
- Issue
- 9
- Pages
- 1191-1197
- ISSN
- 1367-4803 (ISSN-L)
- 1367-4811
- OpenAlex
- W2103068143
- Cited by
- 26
- References
- 36
- Citations by year
- 2022: 1 · 2020: 1 · 2019: 1 · 2017: 1 · 2015: 1 · 2014: 1 · 2013: 5 · 2012: 4
- FWCI
- 1.51
- Type
- journal article
- Language
- en
- Open access
- green
- research.rug.nl
- Licence
- other-oa
- Locations
- Bioinformatics (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- Funders
- Biotechnology and Biological Sciences Research Council (BB/E016065/1, BBC0071581)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene Regulatory Network Analysis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Microbial Metabolic Engineering and Bioproduction
- Physical Sciences › Mathematics › Statistics and Probability › Markov Chains and Monte Carlo Methods
- Keywords
- Bayesian parameter estimation, Markov chain Monte Carlo, off-target effects, drug target identification, Lactococcus lactis, pyruvate metabolism, parameter uncertainty
- MeSH terms
- Algorithms, Artificial Intelligence, Bayes Theorem, Computer Simulation, Data Interpretation, Statistical, Markov Chains, Models, Biological, Monte Carlo Method, Pattern Recognition, Automated, Sensitivity and Specificity, Software, Reproducibility of Results, Signal Transduction, Proteome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.